195 related articles for article (PubMed ID: 23462429)
1. CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers.
Chenoweth MJ; O'Loughlin J; Sylvestre MP; Tyndale RF
Pharmacogenet Genomics; 2013 Apr; 23(4):232-5. PubMed ID: 23462429
[TBL] [Abstract][Full Text] [Related]
2. Associations of CYP2A6 genotype with smoking behaviors in southern China.
Liu T; David SP; Tyndale RF; Wang H; Zhou Q; Ding P; He YH; Yu XQ; Chen W; Crump C; Wen XZ; Chen WQ
Addiction; 2011 May; 106(5):985-94. PubMed ID: 21205058
[TBL] [Abstract][Full Text] [Related]
3. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
[TBL] [Abstract][Full Text] [Related]
4. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.
Malaiyandi V; Lerman C; Benowitz NL; Jepson C; Patterson F; Tyndale RF
Mol Psychiatry; 2006 Apr; 11(4):400-9. PubMed ID: 16402128
[TBL] [Abstract][Full Text] [Related]
5. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Ho MK; Mwenifumbo JC; Al Koudsi N; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2009 Jun; 85(6):635-43. PubMed ID: 19279561
[TBL] [Abstract][Full Text] [Related]
6. CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt.
Cannon DS; Mermelstein RJ; Medina TR; Pugach O; Hedeker D; Weiss RB
Nicotine Tob Res; 2016 May; 18(5):637-41. PubMed ID: 26541911
[TBL] [Abstract][Full Text] [Related]
7. CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer.
Styn MA; Nukui T; Romkes M; Perkins KA; Land SR; Weissfeld JL
Subst Use Misuse; 2013 May; 48(7):490-4. PubMed ID: 23528144
[TBL] [Abstract][Full Text] [Related]
8. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
[TBL] [Abstract][Full Text] [Related]
9. An association of CYP2A6 genotype and smoking topography.
Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI.
Tang DW; Hello B; Mroziewicz M; Fellows LK; Tyndale RF; Dagher A
Neuroimage; 2012 May; 60(4):2136-43. PubMed ID: 22342802
[TBL] [Abstract][Full Text] [Related]
11. Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success.
Chenoweth MJ; Lerman C; Knight J; Tyndale RF
Nicotine Tob Res; 2023 May; 25(6):1207-1211. PubMed ID: 36789481
[TBL] [Abstract][Full Text] [Related]
12. Ethnic differences in nicotine metabolic rate among New Zealanders.
Lea R; Benowitz N; Green M; Fowles J; Vishvanath A; Dickson S; Lea M; Woodward A; Chambers G; Phillips D
N Z Med J; 2005 Dec; 118(1227):U1773. PubMed ID: 16372023
[TBL] [Abstract][Full Text] [Related]
13. Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review.
Jones SK; Wolf BJ; Froeliger B; Wallace K; Carpenter MJ; Alberg AJ
Nicotine Tob Res; 2022 Mar; 24(5):633-642. PubMed ID: 34478556
[TBL] [Abstract][Full Text] [Related]
14. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Chen LS; Bloom AJ; Baker TB; Smith SS; Piper ME; Martinez M; Saccone N; Hatsukami D; Goate A; Bierut L
Addiction; 2014 Jan; 109(1):128-137. PubMed ID: 24033696
[TBL] [Abstract][Full Text] [Related]
16. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
[TBL] [Abstract][Full Text] [Related]
17. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
Audrain-McGovern J; Al Koudsi N; Rodriguez D; Wileyto EP; Shields PG; Tyndale RF
Pediatrics; 2007 Jan; 119(1):e264-74. PubMed ID: 17130279
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
[TBL] [Abstract][Full Text] [Related]
19. Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis.
Altarescu G; Rachmilewitz D; Zevin S
Isr Med Assoc J; 2011 Feb; 13(2):87-90. PubMed ID: 21443033
[TBL] [Abstract][Full Text] [Related]
20. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.
Chenoweth MJ; Sylvestre MP; Contreras G; Novalen M; O'Loughlin J; Tyndale RF
Drug Alcohol Depend; 2016 Jan; 158():139-46. PubMed ID: 26644138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
